Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12007)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2016 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Caparello C, Meijer LL, Garajova I, Falcone A, Le Large TY, Funel N, Kazemier G, Peters GJ, Vasile E, Giovannetti E. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World J Gastroenterol 2016; 22(31): 6987-7005 [PMID: 27610011 DOI: 10.3748/wjg.v22.i31.6987] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i31/6987.htm |
| Number | Citing Articles |
| 1 |
Aurélien Lambert, Céline Gavoille, Thierry Conroy. Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions. Therapeutic Advances in Gastroenterology 2017; 10(8): 631 doi: 10.1177/1756283X17713879
|
| 2 |
Ingrid Hilger. Magnetic Materials and Technologies for Medical Applications. 2022; : 265 doi: 10.1016/B978-0-12-822532-5.00018-2
|
| 3 |
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki, Konstantinos G. Toutouzas. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Current Issues in Molecular Biology 2024; 46(4): 2827 doi: 10.3390/cimb46040177
|
| 4 |
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancer. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(6): 437 doi: 10.1080/17425255.2019.1620731
|
| 5 |
Tessa Ya Sung Le Large, Btissame El Hassouni, Geert Kazemier, Sander R. Piersma, Hanneke W. M. van Laarhoven, Maarten F. Bijlsma, Cornelia R. Jimenez, Elisa Giovannetti. Multidrug‐resistant transporter expression does not always result in drug resistance. Cancer Science 2018; 109(10): 3360 doi: 10.1111/cas.13756
|
| 6 |
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. Pharmacogenomics 2017; 18(14): 1343 doi: 10.2217/pgs-2017-0010
|
| 7 |
Neal Bhutiani, Yan Li, Qianqian Zheng, Harshul Pandit, Xiaoju Shi, Yujia Chen, Youxi Yu, Zachary R. Pulliam, Min Tan, Robert C. G. Martin. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2020; 27(11): 4348 doi: 10.1245/s10434-020-08782-2
|
| 8 |
T.Y.S. Le Large, M.F. Bijlsma, G. Kazemier, H.W.M. van Laarhoven, E. Giovannetti, C.R. Jimenez. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies. Seminars in Cancer Biology 2017; 44: 153 doi: 10.1016/j.semcancer.2017.03.008
|
| 9 |
Tessa Y.S. Le Large, Laura L. Meijer, Rosita Paleckyte, Lenka N.C. Boyd, Bart Kok, Thomas Wurdinger, Tim Schelfhorst, Sander R. Piersma, Thang V. Pham, Nicole C.T. van Grieken, Barbara M. Zonderhuis, Freek Daams, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma, Connie R. Jimenez, Elisa Giovannetti, Geert Kazemier. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach. The Oncologist 2020; 25(4): e634 doi: 10.1634/theoncologist.2019-0680
|
| 10 |
Monique Williams, Gwen Lomberk, Raul Urrutia. Pancreatic Cancer. 2017; : 1 doi: 10.1007/978-1-4939-6631-8_15-2
|
| 11 |
Btissame El Hassouni, Giulia Mantini, Benoît Immordino, Godefridus J. Peters, Elisa Giovannetti. CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage. Molecules 2019; 24(24): 4445 doi: 10.3390/molecules24244445
|
| 12 |
Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World Journal of Gastroenterology 2017; 23(32): 5875-5886 doi: 10.3748/wjg.v23.i32.5875
|
| 13 |
Mjriam Capula, Macarena Perán, Geng Xu, Valentina Donati, Dicky Yee, Alessandro Gregori, Yehuda G. Assaraf, Elisa Giovannetti, Dongmei Deng. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Drug Resistance Updates 2022; 64: 100864 doi: 10.1016/j.drup.2022.100864
|
| 14 |
Rosa Wijnen, Camilla Pecoraro, Daniela Carbone, Hamid Fiuji, Amir Avan, Godefridus J. Peters, Elisa Giovannetti, Patrizia Diana. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 2021; 13(17): 4389 doi: 10.3390/cancers13174389
|
| 15 |
Yongheng Shu, Ping Cheng. Targeting tumor-associated macrophages for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188434 doi: 10.1016/j.bbcan.2020.188434
|
| 16 |
Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Singh, Rajesh Kumar Singh. Xenobiotics in Chemical Carcinogenesis. 2022; : 245 doi: 10.1016/B978-0-323-90560-2.00011-X
|
| 17 |
Rong-Jane Chen, Yi-Jhen Lyu, Yu-Ying Chen, Yen-Chien Lee, Min-Hsiung Pan, Yuan-Soon Ho, Ying-Jan Wang. Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway. Molecules 2021; 26(21): 6741 doi: 10.3390/molecules26216741
|
| 18 |
Lorenzo Fornaro, Francesco Leone, Angélique Vienot, Andrea Casadei-Gardini, Caterina Vivaldi, Astrid Lièvre, Pasquale Lombardi, Emmanuele De Luca, Dewi Vernerey, Elisa Sperti, Gianna Musettini, Maria Antonietta Satolli, Julien Edeline, Rosella Spadi, Cindy Neuzillet, Alfredo Falcone, Giulia Pasquini, Mario Clerico, Alessandro Passardi, Paola Buscaglia, Aurélia Meurisse, Massimo Aglietta, Clémence Brac, Enrico Vasile, Francesco Montagnani. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. Clinical Colorectal Cancer 2019; 18(4): e394 doi: 10.1016/j.clcc.2019.08.004
|
| 19 |
Mahrou Vahabi, Geng Xu, Amir Avan, Godefridus J. Peters, Elisa Giovannetti. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer. Nucleosides, Nucleotides & Nucleic Acids 2024; : 1 doi: 10.1080/15257770.2024.2319215
|
| 20 |
Kang Chen, Manxiong Dai, Quanneng Luo, Yi Wang, Weitao Shen, Yan Liao, Yiying Zhou, Wei Cheng. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. The International Journal of Biochemistry & Cell Biology 2023; 155: 106358 doi: 10.1016/j.biocel.2022.106358
|
| 21 |
Wei Sun, Yong Zhang, Xiaolu Ren, Lingzhi Cui, Jianguo Wang, Xiaohong Ni. <i>In Silico</i> Studies, Biological Activities, and Anti-human Pancreatic Cancer Potential of 6-Hydroxy-4-methylcoumarin and 2,5-Dihydroxyacetophenone as Flavonoid Compounds. Journal of Oleo Science 2022; 71(6): 853 doi: 10.5650/jos.ess22021
|
| 22 |
Ornella Randazzo, Filippo Papini, Giulia Mantini, Alessandro Gregori, Barbara Parrino, Daniel S. K. Liu, Stella Cascioferro, Daniela Carbone, Godefridus J. Peters, Adam E. Frampton, Ingrid Garajova, Elisa Giovannetti. “Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer. Cancers 2020; 12(11): 3206 doi: 10.3390/cancers12113206
|
| 23 |
Xi Cheng, Bingrui Wang, Zhijian Jin, Ding Ma, Weiping Yang, Ren Zhao, Xiaoqian Jing, Baiyong Shen, Chenghong Peng, Weihua Qiu. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling. Oncotarget 2016; 7(47): 77916 doi: 10.18632/oncotarget.12844
|
| 24 |
Nele Van Der Steen, Ingrid Garajova, Christian Rolfo, Andrea Cavazzoni, Elisa Giovannetti. Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. 2019; : 25 doi: 10.1016/B978-0-12-813753-6.00002-0
|
| 25 |
Isaac James Muyinda, Jae-Gwang Park, Eun-Jung Jang, Byong-Chul Yoo. KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism. International Journal of Molecular Sciences 2021; 22(10): 5070 doi: 10.3390/ijms22105070
|
| 26 |
Monique Williams, Gwen Lomberk, Raul Urrutia. Pancreatic Cancer. 2018; : 383 doi: 10.1007/978-1-4939-7193-0_15
|
| 27 |
Annalisa Comandatore, Benoit Immordino, Rita Balsano, Mjriam Capula, Ingrid Garajovà, Joseph Ciccolini, Elisa Giovannetti, Luca Morelli. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. Diagnostics 2022; 12(2): 286 doi: 10.3390/diagnostics12020286
|
| 28 |
Theodoros Michelakos, Cristina R. Ferrone. Pancreatic Cancer. 2018; : 1187 doi: 10.1007/978-1-4939-7193-0_93
|
| 29 |
Ingrid Garajová, Rita Balsano, Heling Wang, Francesco Leonardi, Elisa Giovannetti, Dongmei Deng, Godefridus J. Peters. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Review of Anticancer Therapy 2021; 21(2): 165 doi: 10.1080/14737140.2021.1844007
|
| 30 |
Ingrid Garajová, Rita Balsano, Chiara Tommasi, Elisa Giovannetti. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer. Current Pharmaceutical Design 2019; 24(39): 4601 doi: 10.2174/1381612825666190119125804
|
| 31 |
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
|
| 32 |
A. N. Khitrova, L. V. Bolotina, A. L. Kornietskaya, L. I. Moskvicheva. High-intensity focused ultrasound therapy as part of combined treatment for inoperable pancreatic cancer. Onkologiya. Zhurnal imeni P.A.Gertsena 2020; 9(1): 50 doi: 10.17116/onkolog2020901150
|
| 33 |
Benjamin A. Krantz, Eileen M. O'Reilly. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?. Clinical Cancer Research 2018; 24(10): 2241 doi: 10.1158/1078-0432.CCR-16-3169
|
| 34 |
Mahrou Vahabi, Annalisa Comandatore, Chiara Centra, Giovanni Blandino, Luca Morelli, Elisa Giovannetti. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer. Seminars in Cancer Biology 2023; 97: 50 doi: 10.1016/j.semcancer.2023.11.003
|
| 35 |
Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, Adrian Puerta, Amir Avan, Godefridus J. Peters, Patrizia Diana, Elisa Giovannetti, Daniela Carbone. A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules 2021; 27(1): 19 doi: 10.3390/molecules27010019
|
| 36 |
Mahrou Vahabi, Bilal Dehni, Inés Antomás, Elisa Giovannetti, Godefridus J. Peters. Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma. Cancer and Metastasis Reviews 2023; 42(3): 725 doi: 10.1007/s10555-023-10127-w
|
| 37 |
Daniel Ansari, Fredrik Sambergs, Love Johansson, Roland Andersson. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?. Expert Review of Proteomics 2017; 14(6): 469 doi: 10.1080/14789450.2017.1314787
|
| 38 |
John P. Neoptolemos, David Cunningham, Francesco Sclafani, Paula Ghaneh. Pancreatic Cancer. 2018; : 1039 doi: 10.1007/978-1-4939-7193-0_43
|
| 39 |
Haiyang Du, Gao Si, Jiqing Si, Xuejie Song, Fuchun Si. Single-cell RNA sequencing analysis revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer. Clinics and Research in Hepatology and Gastroenterology 2023; 47(8): 102200 doi: 10.1016/j.clinre.2023.102200
|
| 40 |
Theodoros Michelakos, Cristina R. Ferrone. Pancreatic Cancer. 2017; : 1 doi: 10.1007/978-1-4939-6631-8_93-1
|
| 41 |
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomedicine & Pharmacotherapy 2020; 131: 110768 doi: 10.1016/j.biopha.2020.110768
|
| 42 |
Heike Loeser, Dirk Waldschmidt, Fabian Kuetting, Carina Heydt, Thomas Zander, Patrick Plum, Hakan Alakus, Reinhard Buettner, Alexander Quaas. Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target. Molecular and Clinical Oncology 2017; 6(5): 639 doi: 10.3892/mco.2017.1194
|
| 43 |
Laura L. Meijer, Ingrid Garajová, Chiara Caparello, Tessa Y. S. Le Large, Adam E. Frampton, Enrico Vasile, Niccola Funel, Geert Kazemier, Elisa Giovannetti. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma. Annals of Surgery 2020; 271(6): 1137 doi: 10.1097/SLA.0000000000003084
|
| 44 |
Michael Orth, Philipp Metzger, Sabine Gerum, Julia Mayerle, Günter Schneider, Claus Belka, Maximilian Schnurr, Kirsten Lauber. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1345-6
|
| 45 |
Woonghee Lee, Gwonhwa Song, Hyocheol Bae. Matairesinol Induces Mitochondrial Dysfunction and Exerts Synergistic Anticancer Effects with 5-Fluorouracil in Pancreatic Cancer Cells. Marine Drugs 2022; 20(8): 473 doi: 10.3390/md20080473
|
| 46 |
Motahareh Mortazavi, Elaheh Raufi, Tahereh Damghani, Mehdi Khoshneviszadeh, Najmeh Edraki, Masoomeh Eskandari, Elisa Giovannetti, Godefridus J. Peters, Somayeh Pirhadi, Omidreza Firuzi. Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library. European Journal of Pharmacology 2023; 938: 175395 doi: 10.1016/j.ejphar.2022.175395
|
| 47 |
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, Francesco Leonardi. A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists. Current Oncology 2023; 30(11): 9587 doi: 10.3390/curroncol30110694
|
| 48 |
Muhammad Babar Jamshed, Fahad Munir, Numan Shahid, Ussama Sadiq, Syed Aun Muhammad, Noor Bader Ghanem, Hong Zhong, Xiaokun Li, Qiyu Zhang. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G109 doi: 10.1152/ajpgi.00130.2019
|
| 49 |
Stella Cascioferro, Giovanna Li Petri, Barbara Parrino, Btissame El Hassouni, Daniela Carbone, Vincenzo Arizza, Ugo Perricone, Alessandro Padova, Niccola Funel, Godefridus J. Peters, Girolamo Cirrincione, Elisa Giovannetti, Patrizia Diana. 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma. Molecules 2020; 25(2): 329 doi: 10.3390/molecules25020329
|
| 50 |
Pan Liu, Jiarui Feng, Meng Sun, Wen Yuan, Ruijing Xiao, Jie Xiong, Xiaoxin Huang, Meng Xiong, Wu Chen, Xin Yu, Qian Sun, Xiaojie Zhao, Qiuping Zhang, Liang Shao. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells. International Journal of Oncology 2017; 51(6): 1878 doi: 10.3892/ijo.2017.4153
|
| 51 |
Marika Franczak, Barbara Kutryb-Zajac, Btissame El Hassouni, Elisa Giovannetti, Carlotta Granchi, Filippo Minutolo, Ryszard T. Smolenski, Godefridus J. Peters. The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells. Nucleosides, Nucleotides & Nucleic Acids 2022; 41(12): 1375 doi: 10.1080/15257770.2022.2031215
|
| 52 |
Arthur T.F. Choy, Ilaria Carnevale, Stefano Coppola, Laura L. Meijer, Geert Kazemier, Egija Zaura, Dongmei Deng, Elisa Giovannetti. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine. Expert Review of Molecular Diagnostics 2018; 18(12): 1005 doi: 10.1080/14737159.2018.1544495
|
| 53 |
Laura L. Meijer, Jisce R. Puik, Tessa Y.S. Le Large, Michal Heger, Frederike Dijk, Niccola Funel, Thomas Wurdinger, Ingrid Garajová, Nicole C.T. van Grieken, Mark A. van de Wiel, Elisa Giovannetti, Geert Kazemier. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors. Cancers 2019; 11(8): 1181 doi: 10.3390/cancers11081181
|
| 54 |
John P. Neoptolemos, David Cunningham, Francesco Sclafani, Paula Ghaneh. Pancreatic Cancer. 2016; : 1 doi: 10.1007/978-1-4939-6631-8_43-2
|
| 55 |
Pei Pei Che, Alessandro Gregori, Cecilia Bergonzini, Mahsoem Ali, Giulia Mantini, Thomas Schmidt, Francesco Finamore, Stephanie M. Fraga Rodrigues, Adam E. Frampton, Liam A. McDonnell, Erik H. Danen, Ben J. Slotman, Peter Sminia, Elisa Giovannetti. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells. International Journal of Radiation Oncology*Biology*Physics 2024; 118(5): 1328 doi: 10.1016/j.ijrobp.2023.10.035
|
| 56 |
Ahmed F. Salem, Luca Gambini, Parima Udompholkul, Carlo Baggio, Maurizio Pellecchia. Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents. Pharmaceuticals 2020; 13(5): 90 doi: 10.3390/ph13050090
|
| 57 |
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Amir Avan, Erik H. Danen, Thomas Schmidt, Elisa Giovannetti. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 2023; 15(3): 628 doi: 10.3390/cancers15030628
|
| 58 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
|
| 59 |
Paul Noordhuis, Adrianus C. Laan, Kasper van de Born, Richard J. Honeywell, Godefridus J. Peters. Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines. International Journal of Molecular Sciences 2019; 20(15): 3619 doi: 10.3390/ijms20153619
|
| 60 |
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, Daniela Carbone, Godefridus J. Peters, Patrizia Diana, Yehuda G. Assaraf, Elisa Giovannetti. GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer. Drug Resistance Updates 2021; 58: 100779 doi: 10.1016/j.drup.2021.100779
|